Form 4: Jones Lang LaSalle Director Acquires Shares in Lieu of Cash Compensation
SEC Form 4 Filing
Moses Ifidon Ojeisekhoba, a director at Jones Lang LaSalle Inc. (JLL), acquired 107 shares of common stock on October 1, 2024, in lieu of a cash retainer.
Summary
- On October 1, 2024, Moses Ifidon Ojeisekhoba, a director of Jones Lang LaSalle Inc. (JLL), acquired 107 shares of JLL common stock.
- The shares were received in lieu of a cash retainer payable quarterly in advance for the fourth quarter of fiscal year 2024.
- This acquisition was made in accordance with a prior election under the Non-Executive Director Compensation program.
- The receipt of these shares has been deferred pursuant to the Jones Lang LaSalle Inc. Deferred Compensation Plan.
- Following the transaction, Ojeisekhoba directly owns 4,417 shares of JLL common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director taking shares instead of cash is a slightly positive signal.
Positives
- The director's decision to take shares in lieu of cash may signal confidence in the company's future performance.
Industry Context
Directors receiving shares in lieu of cash compensation is a common practice, particularly in larger companies, as it aligns their interests with those of shareholders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of transaction: Director acquired 107 shares of common stock. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.